Samuel Blackman
Gründer bei DAY ONE BIOPHARMACEUTICALS, INC.
Vermögen: 29 Mio $ am 30.04.2024
Aktive Positionen von Samuel Blackman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 | - |
Gründer | 01.11.2018 | - | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | - |
Karriereverlauf von Samuel Blackman
Ehemalige bekannte Positionen von Samuel Blackman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Corporate Officer/Principal | 01.09.2018 | 01.07.2019 |
ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2016 | 01.09.2018 |
JUNO THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2014 | 01.08.2016 |
Ausbildung von Samuel Blackman
University of Illinois | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Health Technology |
Silverback Therapeutics, Inc.
Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Samuel Blackman
- Erfahrung